AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimibrit M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Elbrit Life Sciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimibrit M 1mg/500mg Tablet

DiaBeta-Duo 1mg/500mg tablets are classified as antidiabetic medications, combining two agents to manage type 2 diabetes in adults. This formulation helps regulate blood glucose. DiaBeta-Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive treatment plan including diet, exercise, and weight management as directed by your doctor; lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may also occur. DiaBeta-Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (assessing blood cell counts and liver function) are recommended.

Primary Ingredients of Glimibrit M 1mg/500mg Tablet

No text provided to rephrase.

Uses of Glimibrit M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimibrit M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimibrit M 1mg/500mg Tablet with food.

Common Side effects of Glimibrit M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimibrit M 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Glimibrit M 1mg/500mg Tablet with a meal.

How Glimibrit M 1mg/500mg Tablet works:

Glimepiride/Metformin 1mg/500mg tablets (Glimibrit M) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose output, inhibiting intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimibrit M 1mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimibrit M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimibrit M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimibrit M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimibrit M 1mg/500mg tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimibrit M 1mg/500mg tablets cautiously. Dosage modification may be necessary. Medical advice is recommended. A low starting dose is typically used for those with mild to moderate liver disease; the medication is contraindicated in patients with severe liver disease.

What if you forget to take Glimibrit M 1mg/500mg Tablet :

Should you forget a dose of Glimibrit M 1mg/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimibrit M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimibrit M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimibrit M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. Seek immediate medical attention, including discontinuing Glimibrit M 1mg/500mg Tablets, if these symptoms occur.
Glimibrit M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glimibrit M 1mg/500mg tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimibrit M 1mg/500mg Tablet use can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Glimibrit M 1mg/500mg tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimibrit M 1mg/500mg tablets and alcohol is unsafe. Alcohol can exacerbate the medication's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Glimibrit M 1mg/500mg Tab...
98
MRP 120
18% off